{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:36:06Z","timestamp":1753889766371,"version":"3.41.2"},"reference-count":88,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Since the advent of the COVID-19 pandemic in 2019, a mammoth research activity targeting\nthe etiological features of COVID-19 has commenced. Many aspects of the disease have been studied,\nand various others are under consideration. The secondary microbial coinfections with COVID-19\nhave generated some serious concerns across the globe. This review mainly focuses on the notable\nsecondary coinfections. The coinfection of influenza, tuberculosis, and typhoid may mimic the original\nCOVID-19 symptoms. Physicians and clinicians must focus on the secondary coinfections which may\naggravate the disease progression towards acute respiratory disorder syndrome (ARDS). Diagnostic\nstrategies must also be redefined to determine the actual underlying secondary coinfection. There is a\nneed for combination therapy and diagnostic approaches to minimize the risks associated with the\nCOVID-19 pandemic effectively.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871526522666220407001744","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T10:59:01Z","timestamp":1649329141000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 and Coinfections: A Serious Health Threat Requires Combination\nof Diagnosis and Therapy"],"prefix":"10.2174","volume":"22","author":[{"given":"Shahid","family":"Nawaz","sequence":"first","affiliation":[{"name":"Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maira","family":"Saleem","sequence":"additional","affiliation":[{"name":"Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"WHO. WHO Coronavirus (COVID-19) Dashboard, 2022. Available from:"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/JCMA.0000000000000270","volume":"83","author":"Wu Y.C.","year":"2020","unstructured":"Wu Y.C.; Chen C.S.; Chan Y.J.; The outbreak of COVID-19: An overview. J Chin Med Assoc 2020,83(3),217-220","journal-title":"J Chin Med Assoc"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/v13010040","volume":"13","author":"Machado B.A.S.","year":"2020","unstructured":"Machado B.A.S.; Hodel K.V.S.; Barbosa-J\u00fanior V.G.; Soares M.B.P.; Badar\u00f3 R.; The main molecular and serological methods for diagnosing COVID-19: An overview based on the literature. Viruses 2020,13(1),40","journal-title":"Viruses"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","volume":"26","author":"Long Q.X.","year":"2020","unstructured":"Long Q.X.; Tang X.J.; Shi Q.L.; Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 2020,26(8),1200-1204","journal-title":"Nat Med"},{"key":"ref=5","doi-asserted-by":"publisher","DOI":"10.2174\/1871526520666201006163641","volume":"2020","author":"Nawaz S.","year":"2020","unstructured":"Nawaz S.; COVID-19, SARS -CoV-2, origin, transmission and treatment aspects, a brief review. Infect Disord Drug Targets 2020,2020","journal-title":"Infect Disord Drug Targets"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jare.2020.03.005","volume":"24","author":"Shereen M.A.","year":"2020","unstructured":"Shereen M.A.; Khan S.; Kazmi A.; Bashir N.; Siddique R.; COVID-19 infection: Origin, transmission, and characteristics of human corona-viruses. J Adv Res 2020,24,91-98","journal-title":"J Adv Res"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1126\/science.abb3221","volume":"368","author":"Li R.","year":"2020","unstructured":"Li R.; Pei S.; Chen B.; Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science 2020,368(6490),489-493","journal-title":"Science"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jmii.2020.05.013","volume":"53","author":"Lai C.C.","year":"2020","unstructured":"Lai C.C.; Wang C.Y.; Hsueh P.R.; Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect 2020,53(4),505-512","journal-title":"J Microbiol Immunol Infect"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2174\/1871523019666201202092859","volume":"20","author":"Mohamed A.A.","year":"2021","unstructured":"Mohamed A.A.; Tantawi O.I.; Fathalla L.A.; COVID-19: Urgent call to action. Antiinflamm Antiallergy Agents Med Chem 2021,20(2),118-122","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2174\/1871526520666200520112848","volume":"21","author":"Mohamed A.A.","year":"2021","unstructured":"Mohamed A.A.; Mohamed N.; Mohamoud S.; SARS-CoV-2: The path of prevention and control. Infect Disord Drug Targets 2021,21(3),358-362","journal-title":"Infect Disord Drug Targets"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1021\/acsnano.0c03402","volume":"14","author":"Kalantar-Zadeh K.","year":"2020","unstructured":"Kalantar-Zadeh K.; Ward S.A.; Kalantar-Zadeh K.; El-Omar E.M.; Considering the effects of microbiome and diet on SARS-CoV-2 infection: Nanotechnology roles. ACS Nano 2020,14(5),5179-5182","journal-title":"ACS Nano"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1873494","DOI":"10.1080\/20008686.2021.1873494","volume":"11","author":"Rana M.S.","year":"2021","unstructured":"Rana M.S.; Usman M.; Alam M.M.; Ikram A.; Salman M.; Overlapping clinical manifestations of COVID-19 with endemic infectious diseases in Pakistan: A looming threat of multiple lethal combinations. Infect Ecol Epidemiol 2021,11(1),1873494","journal-title":"Infect Ecol Epidemiol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/myc.13137","volume":"63","author":"Salehi M.","year":"2020","unstructured":"Salehi M.; Ahmadikia K.; Mahmoudi S.; Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: Species identification and antifungal susceptibility pattern. Mycoses 2020,63(8),771-778","journal-title":"Mycoses"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1101\/2021.02.02.21250995","author":"Gebrecherkos T.","year":"2021","unstructured":"Gebrecherkos T.; Gessesse Z.; Kebede Y.; Effect of co-infection with parasites on severity of COVID-19. MedRxiv 2021","journal-title":"MedRxiv"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"Chen N.","year":"2020","unstructured":"Chen N.; Zhou M.; Dong X.; Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020,395(10223),507-513","journal-title":"Lancet"},{"key":"ref=16","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.02.20030452","author":"Zhang G.","year":"2020","unstructured":"Zhang G.; Hu C.; Luo L.; Clinical features and outcomes of 221 patients with COVID-19 in Wuhan, China. MedRxiv 2020","journal-title":"MedRxiv"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jmv.26144","volume":"93","author":"Haqqi A.","year":"2021","unstructured":"Haqqi A.; Awan U.A.; Ali M.; Saqib M.A.; Ahmed H.; Afzal M.S.; COVID\u201019 and dengue virus co\u2010epidemics in Pakistan: A dangerous combina-tion for overburdened healthcare system. J Med Virol 2021,93(1),80-82","journal-title":"J Med Virol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"taab019","DOI":"10.1093\/jtm\/taab019","volume":"28","author":"Ayoubzadeh S.I.","year":"2021","unstructured":"Ayoubzadeh S.I.; Isabel S.; Coomes E.A.; Morris S.K.; Enteric fever and COVID-19 co-infection in a teenager returning from Pakistan. J Travel Med 2021,28(3),taab019","journal-title":"J Travel Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.puhip.2021.100084","volume":"2","author":"Ahmad S.","year":"2021","unstructured":"Ahmad S.; Tsagkaris C.; Aborode A.T.; A skeleton in the closet: The implications of COVID-19 on XDR strain of typhoid in Pakistan. Public Health in Practice 2021,2,100084","journal-title":"Public Health in Practice"},{"key":"ref=20","unstructured":"National Institute of Health Islamabad. Weekly field epidemiology report 2020. Available from:"},{"key":"ref=21","unstructured":"Government of Pakistan. 2021. Pakistan cases details. Available from:"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"17846","DOI":"10.1038\/s41598-020-74913-0","volume":"10","author":"Wang J.G.","year":"2020","unstructured":"Wang J.G.; Cui H.R.; Tang H.B.; Deng X.L.; Gastrointestinal symptoms and fecal nucleic acid testing of children with 2019 coronavirus disease: A systematic review and meta-analysis. Sci Rep 2020,10(1),17846","journal-title":"Sci Rep"},{"key":"ref=23","unstructured":"Centers for Disease Control and Prevention 2020. Available from:"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s10096-020-03874-z","volume":"39","author":"Ge H.","year":"2020","unstructured":"Ge H.; Wang X.; Yuan X.; The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis 2020,39(6),1011-1019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ijid.2020.05.068","volume":"96","author":"Ma S.","year":"2020","unstructured":"Ma S.; Lai X.; Chen Z.; Tu S.; Qin K.; Clinical characteristics of critically ill patients co-infected with SARS-CoV-2 and the influenza virus in Wuhan, China. Int J Infect Dis 2020,96,683-687","journal-title":"Int J Infect Dis"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"104554","DOI":"10.1016\/j.micpath.2020.104554","volume":"152","author":"Khorramdelazad H.","year":"2021","unstructured":"Khorramdelazad H.; Kazemi M.H.; Najafi A.; Keykhaee M.; Zolfaghari Emameh R.; Falak R.; Immunopathological similarities between COVID-19 and influenza: Investigating the consequences of Co-infection. Microb Pathog 2021,152,104554","journal-title":"Microb Pathog"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/jmv.26120","volume":"93","year":"2020","unstructured":"Mar\u00edn\u2010Hern\u00e1ndez D, Schwartz RE, Nixon DF. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID\u201019 deaths in Italy. J Med Virol 2020,93(1),64-65","journal-title":"J Med Virol"},{"key":"ref=28","unstructured":"News channel 20. Health experts warn about \"twindemic\" cases of flu and COVID-19. Available from:"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"649570","DOI":"10.1155\/2012\/649570","volume":"2012","author":"Min J.Y.","year":"2012","unstructured":"Min J.Y.; Jang Y.J.; Macrolide therapy in respiratory viral infections. Mediators Inflamm 2012,2012,649570","journal-title":"Mediators Inflamm"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5582\/bst.2020.03058","volume":"14","author":"Ohe M.","year":"2020","unstructured":"Ohe M.; Shida H.; Jodo S.; Macrolide treatment for COVID-19: Will this be the way forward? Biosci Trends 2020,14(2),159-160","journal-title":"Biosci Trends"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jmii.2020.03.034","volume":"53","author":"Jean S.S.","year":"2020","unstructured":"Jean S.S.; Lee P.I.; Hsueh P.R.; Treatment options for COVID-19: The reality and challenges. J Microbiol Immunol Infect 2020,53(3),436-443","journal-title":"J Microbiol Immunol Infect"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.antiviral.2013.09.015","volume":"100","author":"Furuta Y.","year":"2013","unstructured":"Furuta Y.; Gowen B.B.; Takahashi K.; Shiraki K.; Smee D.F.; Barnard D.L.; Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res 2013,100(2),446-454","journal-title":"Antiviral Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00705-021-04956-9","volume":"166","author":"Dabbous H.M.","year":"2021","unstructured":"Dabbous H.M.; Abd-Elsalam S.; El-Sayed M.H.; Efficacy of favipiravir in COVID-19 treatment: A multi-center randomized study. Arch Virol 2021,166(3),949-954","journal-title":"Arch Virol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3390\/nu12040988","volume":"12","author":"Grant W.B.","year":"2020","unstructured":"Grant W.B.; Lahore H.; McDonnell S.L.; Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infec-tions and deaths. Nutrients 2020,12(4),988","journal-title":"Nutrients"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/jmv.26272","volume":"93","author":"Ozaras R.","year":"2020","unstructured":"Ozaras R.; Cirpin R.; Duman H.; Duran A.; Arslan O.; Leblebicioglu H.; An open call for influenza vaccination pending the new wave of COVID-19. J Med Virol 2020,93(1),172-173","journal-title":"J Med Virol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1386-6532(03)00010-6","volume":"27","author":"Guzman M.G.","year":"2003","unstructured":"Guzman M.G.; Kouri G.; Dengue and dengue hemorrhagic fever in the Americas: Lessons and challenges. J Clin Virol 2003,27(1),1-13","journal-title":"J Clin Virol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S1473-3099(20)30158-4","volume":"20","author":"Yan G.","year":"2020","unstructured":"Yan G.; Lee C.K.; Lam L.T.M.; Covert COVID-19 and false-positive dengue serology in Singapore. Lancet Infect Dis 2020,20(5),536","journal-title":"Lancet Infect Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"e177","DOI":"10.1016\/j.jaad.2020.03.036","volume":"82","author":"Joob B.","year":"2020","unstructured":"Joob B.; Wiwanitkit V.; COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol 2020,82(5),e177","journal-title":"J Am Acad Dermatol"},{"author":"Biswas S.","key":"ref=39","doi-asserted-by":"publisher","unstructured":"Biswas S.; Sukla S.; COVID-19 virus infection and transmission are observably less in highly Dengue-endemic countries: Can Dengue vac-cines be \u201crepurposed\u201d to prevent COVID-19? 2020","DOI":"10.31487\/j.CEI.2020.02.05"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijid.2020.10.043","volume":"102","author":"Masyeni S.","year":"2021","unstructured":"Masyeni S.; Santoso M.S.; Widyaningsih P.D.; Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia. Int J Infect Dis 2021,102,152-154","journal-title":"Int J Infect Dis"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/jmv.26269","volume":"93","author":"Miah M.A.","year":"2021","unstructured":"Miah M.A.; Husna A.; Coinfection, coepidemics of COVID-19, and dengue in dengue-endemic countries: A serious health concern. J Med Virol 2021,93(1),161-162","journal-title":"J Med Virol"},{"key":"ref=42","unstructured":"World Health Organization. Global tuberculosis report 2013. World Health Organization. 2013. Available from:  Accessed on: 15th November 2020."},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"707287","DOI":"10.3389\/fimmu.2021.707287","volume":"12","author":"Zheng W.","year":"2021","unstructured":"Zheng W.; Wu H.; Liu C.; Identification of COVID-19 and dengue host factor interaction networks based on integrative bioinformatics analyses. Front Immunol 2021,12,707287","journal-title":"Front Immunol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.arbres.2020.11.016","volume":"57","author":"Comella-Del-Barrio P.","year":"2021","unstructured":"Comella-Del-Barrio P.; De Souza-Galv\u00e3o M.L.; Prat-Aymerich C.; Dom\u00ednguez J.; Impact of COVID-19 on tuberculosis control. Arch Bronconeumol 2021,57,5-6","journal-title":"Arch Bronconeumol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2478\/jtim-2020-0010","volume":"8","author":"Yang H.","year":"2020","unstructured":"Yang H.; Lu S.; COVID-19 and tuberculosis. J Transl Int Med 2020,8(2),59-65","journal-title":"J Transl Int Med"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2001718","DOI":"10.1183\/13993003.01718-2020","volume":"56","author":"McQuaid C.F.","year":"2020","unstructured":"McQuaid C.F.; McCreesh N.; Read J.M.; The potential impact of COVID-19-related disruption on tuberculosis burden. Eur Respir J 2020,56(2),2001718","journal-title":"Eur Respir J"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2001348","DOI":"10.1183\/13993003.01348-2020","volume":"56","author":"Saunders M.J.","year":"2020","unstructured":"Saunders M.J.; Evans C.A.; COVID-19, tuberculosis and poverty: Preventing a perfect storm. Eur Respir J 2020,56(1),2001348","journal-title":"Eur Respir J"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S1470-2045(20)30309-0","volume":"21","author":"Tian J.","year":"2020","unstructured":"Tian J.; Yuan X.; Xiao J.; Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: A multicentre, retrospective, cohort study. Lancet Oncol 2020,21(7),893-903","journal-title":"Lancet Oncol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"971","DOI":"10.5588\/ijtld.20.0417","volume":"24","author":"Echeverr\u00eda G.","year":"2020","unstructured":"Echeverr\u00eda G.; Espinoza W.; de Waard J.H.; How TB and COVID-19 compare: An opportunity to integrate both control programmes. Int J Tuberc Lung Dis 2020,24(9),971-974","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.2214\/AJR.20.22976","volume":"214","author":"Zhao W.","year":"2020","unstructured":"Zhao W.; Zhong Z.; Xie X.; Yu Q.; Liu J.; Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: A multicenter study. AJR Am J Roentgenol 2020,214(5),1072-1077","journal-title":"AJR Am J Roentgenol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1080\/23744235.2020.1806353","volume":"52","author":"Sy K.T.L.","year":"2020","unstructured":"Sy K.T.L.; Haw N.J.L.; Uy J.; Previous and active tuberculosis increases risk of death and prolongs recovery in patients with COVID-19. Infect Dis (Lond) 2020,52(12),902-907","journal-title":"Infect Dis (Lond)"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/jmv.26311","volume":"93","author":"Gao Y.","year":"2021","unstructured":"Gao Y.; Liu M.; Chen Y.; Shi S.; Geng J.; Tian J.; Association between tuberculosis and COVID-19 severity and mortality: A rapid systematic review and meta-analysis. J Med Virol 2021,93(1),194-196","journal-title":"J Med Virol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"2002328","DOI":"10.1183\/13993003.02328-2020","volume":"56","author":"Tadolini M.","year":"2020","unstructured":"Tadolini M.; Garc\u00eda-Garc\u00eda J.M.; Blanc F.X.; On tuberculosis and COVID-19 co-infection. Eur Respir J 2020,56(2),2002328","journal-title":"Eur Respir J"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"2000650","DOI":"10.1183\/13993003.00650-2020","volume":"55","author":"Alagna R.","year":"2020","unstructured":"Alagna R.; Besozzi G.; Codecasa L.R.; Celebrating world tuberculosis day at the time of COVID-19. Eur Respir J 2020,55(4),2000650","journal-title":"Eur Respir J"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12890-019-0971-y","volume":"19","author":"Getnet F.","year":"2019","unstructured":"Getnet F.; Demissie M.; Worku A.; Delay in diagnosis of pulmonary tuberculosis increases the risk of pulmonary cavitation in pastoral-ist setting of Ethiopia. BMC Pulm Med 2019,19(1),201","journal-title":"BMC Pulm Med"},{"key":"ref=56","doi-asserted-by":"publisher","DOI":"10.4081\/monaldi.2020.1368","volume":"90","author":"Singh A.","year":"2020","unstructured":"Singh A.; Prasad R.; Gupta A.; Das K.; Gupta N.; Severe acute respiratory syndrome coronavirus-2 and pulmonary tuberculosis: Convergence can be fatal. Monaldi Arch Chest Dis 2020,90(3)","journal-title":"Monaldi Arch Chest Dis"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.pulmoe.2020.12.012","volume":"27","author":"Visca D.","year":"2021","unstructured":"Visca D.; Ong C.W.M.; Tiberi S.; Tuberculosis and COVID-19 interaction: A review of biological, clinical and public health effects. Pulmonology 2021,27(2),151-165","journal-title":"Pulmonology"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3906\/sag-2007-133","volume":"51","year":"2021","unstructured":"Sarialio\u011flu F, Belen FB, Hayran KM. Hepatitis A susceptibility parallels high COVID-19 mortality. Turk J Med Sci 2021,51(1),382-384","journal-title":"Turk J Med Sci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1473-3099(15)00218-2","volume":"16","author":"Liu J.","year":"2016","unstructured":"Liu J.; Zhang S.; Wang Q.; Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: A popula-tion-based, cross-sectional study. Lancet Infect Dis 2016,16(1),80-86","journal-title":"Lancet Infect Dis"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2018.35","volume":"4","author":"Yuen M.F.","year":"2018","unstructured":"Yuen M.F.; Chen D.S.; Dusheiko G.M.; Hepatitis B virus infection. N Rev Dis Pimers 2018,4(1),1-20","journal-title":"N Rev Dis Pimers"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2468-1253(18)30412-6","volume":"4","author":"Cunningham C.","year":"2019","unstructured":"Cunningham C.; Accelerating the elimination of viral hepatitis for Indigenous peoples. Lancet Gastroenterol Hepatol 2019,4(2),93-94","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cgh.2020.06.017","volume":"19","author":"Zou X.","year":"2021","unstructured":"Zou X.; Fang M.; Li S.; Characteristics of liver function in patients with SARS-CoV-2 and chronic HBV coinfection. Clin Gastroenterol Hepatol 2021,19(3),597-603","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2020.05.002","volume":"73","author":"Wang Y.","year":"2020","unstructured":"Wang Y.; Liu S.; Liu H.; SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol 2020,73(4),807-816","journal-title":"J Hepatol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"e13338","DOI":"10.1111\/eci.13338","volume":"50","author":"Portincasa P.","year":"2020","unstructured":"Portincasa P.; Krawczyk M.; Smyk W.; Lammert F.; Di Ciaula A.; COVID-19 and non-alcoholic fatty liver disease: Two intersecting pandem-ics. Eur J Clin Invest 2020,50(10),e13338","journal-title":"Eur J Clin Invest"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1111\/jvh.13362","volume":"27","author":"Chen L.","year":"2020","unstructured":"Chen L.; Huang S.; Yang J.; Clinical characteristics in patients with SARS-CoV-2\/HBV co-infection. J Viral Hepat 2020,27(12),1504-1507","journal-title":"J Viral Hepat"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/jvh.13404","volume":"28","author":"Wu J.","year":"2021","unstructured":"Wu J.; Yu J.; Shi X.; Epidemiological and clinical characteristics of 70 cases of coronavirus disease and concomitant hepatitis B virus infection: A multicentre descriptive study. J Viral Hepat 2021,28(1),80-88","journal-title":"J Viral Hepat"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3851\/IMP3382","volume":"25","author":"Alqahtani S.A.","year":"2020","unstructured":"Alqahtani S.A.; Buti M.; COVID-19 and hepatitis B infection. Antivir Ther 2020,25(8),389-397","journal-title":"Antivir Ther"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e004275","DOI":"10.1136\/bmjgh-2020-004275","volume":"6","author":"Pley C.M.","year":"2021","unstructured":"Pley C.M.; McNaughton A.L.; Matthews P.C.; Louren\u00e7o J.; The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection. BMJ Glob Health 2021,6(1),e004275","journal-title":"BMJ Glob Health"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S2468-1253(19)30046-9","volume":"4","author":"Indolfi G.","year":"2019","unstructured":"Indolfi G.; Easterbrook P.; Dusheiko G.; Hepatitis C virus infection in children and adolescents. Lancet Gastroenterol Hepatol 2019,4(6),477-487","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0140-6736(16)30579-7","volume":"388","author":"Stanaway J.D.","year":"2016","unstructured":"Stanaway J.D.; Flaxman A.D.; Naghavi M.; The global burden of viral hepatitis from 1990 to 2013: Findings from the Global Burden of Disease Study 2013. Lancet 2016,388(10049),1081-1088","journal-title":"Lancet"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/hep.31281","volume":"72","author":"Fix O.K.","year":"2020","unstructured":"Fix O.K.; Hameed B.; Fontana R.J.; Clinical best practice advice for hepatology and liver transplant providers during the COVID-19 pan-demic: AASLD expert panel consensus statement. Hepatology 2020,72(1),287-304","journal-title":"Hepatology"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/liv.14435","volume":"40","author":"Xu L.","year":"2020","unstructured":"Xu L.; Liu J.; Lu M.; Yang D.; Zheng X.; Liver injury during highly pathogenic human coronavirus infections. Liver Int 2020,40(5),998-1004","journal-title":"Liver Int"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"100113","DOI":"10.1016\/j.jhepr.2020.100113","volume":"2","author":"Boettler T.","year":"2020","unstructured":"Boettler T.; Newsome P.N.; Mondelli M.U.; Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper. JHEP Rep 2020,2(3),100113","journal-title":"JHEP Rep"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S2468-1253(20)30190-4","volume":"5","author":"Wong G.L.","year":"2020","unstructured":"Wong G.L.; Wong V.W.; Thompson A.; Management of patients with liver derangement during the COVID-19 pandemic: An Asia-Pacific position statement. Lancet Gastroenterol Hepatol 2020,5(8),776-787","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14787210.2021.1950532","author":"El-Bendary M.","year":"2021","unstructured":"El-Bendary M.; Abd-Elsalam S.; Elbaz T.; Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: A multicenter Egyptian study. Expert Rev Anti Infect Ther 2021,1-5","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","volume":"11","author":"Sheahan T.P.","year":"2020","unstructured":"Sheahan T.P.; Sims A.C.; Leist S.R.; Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun 2020,11(1),222","journal-title":"Nat Commun"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"104541","DOI":"10.1016\/j.antiviral.2019.104541","volume":"169","author":"Brown A.J.","year":"2019","unstructured":"Brown A.J.; Won J.J.; Graham R.L.; Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase. Antiviral Res 2019,169,104541","journal-title":"Antiviral Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"Wang M.","year":"2020","unstructured":"Wang M.; Cao R.; Zhang L.; Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020,30(3),269-271","journal-title":"Cell Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"Beigel J.H.","year":"2020","unstructured":"Beigel J.H.; Tomashek K.M.; Dodd L.E.; Remdesivir for the treatment of COVID-19-preliminary report. N Engl J Med 2020,383(19),1813-1826","journal-title":"N Engl J Med"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4269\/ajtmh.21-0606","author":"Abd-Elsalam S.","year":"2021","unstructured":"Abd-Elsalam S.; Ahmed O.A.; Mansour N.O.; Remdesivir efficacy in COVID-19 treatment: A randomized controlled trial. Am J Trop Med Hyg 2021,1","journal-title":"Am J Trop Med Hyg"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhep.2020.07.042","volume":"74","author":"Blach S.","year":"2021","unstructured":"Blach S.; Kondili L.A.; Aghemo A.; Impact of COVID-19 on global HCV elimination efforts. J Hepatol 2021,74(1),31-36","journal-title":"J Hepatol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"Guan W.J.","year":"2020","unstructured":"Guan W.J.; Ni Z.Y.; Hu Y.; Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020,382(18),1708-1720","journal-title":"N Engl J Med"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"102(3): 543-64","DOI":"10.1007\/BF01932420","author":"Paltauf A.","year":"1885","unstructured":"Paltauf A.;  Mycosis mucorina Archives for pathological anatomy and physiology and for clinical medicine 1885,102(3): 543-64","journal-title":"Mycosis mucorina Archives for pathological anatomy and physiology and for clinical medicine"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1001\/jama.1957.02970450007003","volume":"163","author":"Baker R.D.","year":"1957","unstructured":"Baker R.D.; Mucormycosis: A new disease? J Am Med Assoc 1957,163(10),805-808","journal-title":"J Am Med Assoc"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1439-0507.2001.00656.x","volume":"44","author":"Eucker J.","year":"2001","unstructured":"Eucker J.; Sezer O.; Graf B.; Possinger K.; Mucormycoses. Mycoses 2001,44(7-8),253-260","journal-title":"Mycoses"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","volume":"15","author":"Singh A.K.","year":"2021","unstructured":"Singh A.K.; Singh R.; Joshi S.R.; Misra A.; Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021,15(4),102146","journal-title":"Diabetes Metab Syndr"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"bcr2016215855","DOI":"10.1136\/bcr-2016-215855","volume":"2016","author":"Mulki R.","year":"2016","unstructured":"Mulki R.; Masab M.; Eiger G.; Perloff S.; Lethargy and vision loss: Successful management of rhinocerebral mucormycosis. BMJ Case Rep 2016,2016,bcr2016215855","journal-title":"BMJ Case Rep"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"15","DOI":"10.52700\/jmmg.v2i1.20","volume":"2","author":"Nawaz S.","year":"2021","unstructured":"Nawaz S.; Saleem M.; Mucormycosis, the black fungus alarming coinfections in COVID-19 patients. J Microbiol Mol Gen 2021,2(1),15-18","journal-title":"J Microbiol Mol Gen"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871526522666220407001744","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/203215\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871526522666220407001744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T18:18:04Z","timestamp":1693160284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/203215\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":88,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871526522666220407001744","relation":{},"ISSN":["1871-5265"],"issn-type":[{"type":"print","value":"1871-5265"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-10-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e070422203215"}}